BR9408452A - Processo para preparação de um composto e composto obtido - Google Patents

Processo para preparação de um composto e composto obtido

Info

Publication number
BR9408452A
BR9408452A BR9408452A BR9408452A BR9408452A BR 9408452 A BR9408452 A BR 9408452A BR 9408452 A BR9408452 A BR 9408452A BR 9408452 A BR9408452 A BR 9408452A BR 9408452 A BR9408452 A BR 9408452A
Authority
BR
Brazil
Prior art keywords
compound
formula
preparing
het
compound obtained
Prior art date
Application number
BR9408452A
Other languages
English (en)
Inventor
Mahadevan Bhupathy
James M Mcnamara
Daniel R Silder
Ralph P Volante
James J Bergan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26870681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9408452(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BR9408452A publication Critical patent/BR9408452A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/53—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
BR9408452A 1993-12-28 1994-12-22 Processo para preparação de um composto e composto obtido BR9408452A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17493193A 1993-12-28 1993-12-28
US35042894A 1994-12-09 1994-12-09
PCT/US1994/014858 WO1995018107A1 (en) 1993-12-28 1994-12-22 Process for the preparation of leukotriene antagonists

Publications (1)

Publication Number Publication Date
BR9408452A true BR9408452A (pt) 1997-08-05

Family

ID=26870681

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408452A BR9408452A (pt) 1993-12-28 1994-12-22 Processo para preparação de um composto e composto obtido

Country Status (29)

Country Link
US (2) US5614632A (pt)
EP (1) EP0737186B1 (pt)
JP (1) JP3640962B2 (pt)
KR (1) KR100319336B1 (pt)
CN (3) CN1046712C (pt)
AT (1) ATE169906T1 (pt)
AU (1) AU686303B2 (pt)
BG (1) BG62850B1 (pt)
BR (1) BR9408452A (pt)
CA (1) CA2179407C (pt)
CY (1) CY2104B1 (pt)
CZ (1) CZ286079B6 (pt)
DE (1) DE69412644T2 (pt)
DK (1) DK0737186T3 (pt)
ES (1) ES2122534T3 (pt)
FI (1) FI113045B (pt)
GE (1) GEP20012387B (pt)
HK (1) HK1009269A1 (pt)
HR (1) HRP941022B1 (pt)
HU (1) HU226394B1 (pt)
LV (1) LV12313B (pt)
NZ (1) NZ278263A (pt)
PL (1) PL178671B1 (pt)
RO (1) RO119018B1 (pt)
RU (2) RU2140909C1 (pt)
TW (2) TW448160B (pt)
UA (1) UA44724C2 (pt)
WO (1) WO1995018107A1 (pt)
YU (1) YU49412B (pt)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
CA2395834A1 (en) * 1999-12-28 2001-07-05 Tetsuo Kawaguchi Tricyclic compounds
CN1318400C (zh) * 2002-02-06 2007-05-30 戴尔玛化学品股份有限公司 制备1－(巯基甲基)－环丙烷乙酸的方法
AU2003209043A1 (en) * 2002-02-07 2003-09-02 Dr. Reddy's Laboratories Ltd. Novel anhydrous amorphous forms of montelukast sodium salt
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
US7560559B2 (en) * 2003-04-15 2009-07-14 Merck & Co., Inc. Polymorphic form of montelukast sodium
AU2004234235A1 (en) 2003-04-25 2004-11-11 Nippon Chemiphar Co., Ltd. Salt of (2s,3s)-3-[[(1s)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid
US8450491B2 (en) * 2003-06-06 2013-05-28 Morepen Laboratories Limited Method for the preparation of montelukast acid and sodium salt thereof in amorphous form
EP1678139B1 (en) 2003-10-10 2011-08-31 Synhton B.V. Solid-state montelukast
US20050187243A1 (en) * 2004-01-30 2005-08-25 Valerie Niddam-Hildesheim Montelukast free acid polymorphs
EP1760077A1 (en) * 2004-01-30 2007-03-07 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs
WO2005075427A2 (en) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast sodium polymorphs
BRPI0506610A (pt) 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
MXPA06012220A (es) * 2004-04-21 2007-07-18 Teva Pharma Procesos para preparar sodio de montelukast.
US7501517B2 (en) 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US20090143590A1 (en) * 2004-07-19 2009-06-04 Matrix Laboratories Ltd. Process for the Preparation of Montelukast and its Salts
WO2006008750A2 (en) * 2004-07-19 2006-01-26 Matrix Laboratories Ltd Methyl 2-[(3s)-[3-[(2e)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates
WO2006021974A1 (en) * 2004-08-23 2006-03-02 Morepen Laboratories Limited A process for synthesizing diol (viii)-an intermediate of montelukast sodium
PL205637B1 (pl) * 2004-10-22 2010-05-31 Inst Farmaceutyczny Sposób wytwarzania kwasu (R,E)-(1-{1-{3-[2-(7-chlorochinolin-2-ylo)etenylo]fenylo}-3-[2-(1-hydroksy-1-metyloetylo)fenylo] propylosulfanylometylo}cyklopropylo)octowego i/lub jego farmaceutycznie dopuszczalnych soli
WO2006054317A1 (en) * 2004-11-19 2006-05-26 Matrix Laboratories Ltd Process for the preparation of novel amorphous montelukast sodium
US20080214822A1 (en) * 2004-11-30 2008-09-04 Medichem, S.A. Process For the Preparation of a Leukotriene Antagonist
ITMI20050247A1 (it) * 2005-02-18 2006-08-19 Chemi Spa Processo per la preparazione di montelukast
US7812168B2 (en) * 2005-07-05 2010-10-12 Teva Pharmaceutical Industries Ltd. Purification of montelukast
EP1912499A4 (en) * 2005-07-20 2010-03-31 Reddys Lab Ltd Dr PREPARATION OF MONTELUKAST
EP1783117A1 (en) * 2005-11-04 2007-05-09 Esteve Quimica, S.A. Process for the preparation of a leukotriene antagonist and intermediates thereof
US20070161796A1 (en) * 2005-11-16 2007-07-12 Ilan Kor-Sade Drying methods of montelukast sodium by azeotropic removal of the solvent
AR057908A1 (es) 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast e intermediarios del mismo
EP1968943B1 (en) * 2005-12-13 2013-01-23 MSN Laboratories Limited An improved process for the preparation of montelukast and its pharmaceutically acceptable salts
CA2632954A1 (en) * 2005-12-23 2007-06-28 Glade Organics Private Limited An improved process for the manufacture of montelukast sodium
EP1976522B2 (en) 2005-12-30 2019-07-03 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition containing montelukast
US7572930B2 (en) * 2006-02-02 2009-08-11 Chemagis Ltd. Process for preparing 1-(mercaptomethyl)cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof
WO2007092031A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
CA2643228A1 (en) * 2006-02-21 2007-08-30 Chemagis Ltd. Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
WO2007096889A2 (en) * 2006-02-27 2007-08-30 Chemagis Ltd. Process for preparing montelukast and salts thereof
EP1996552A1 (en) 2006-03-17 2008-12-03 Synthon B.V. Montelukast amantadine salt
CA2649189A1 (en) * 2006-04-12 2007-10-18 Glade Organics Private Limited An improved process for the manufacture of montelukast sodium
WO2008001213A1 (en) * 2006-06-26 2008-01-03 Aurobindo Pharma Limited An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium)
GB0614485D0 (en) * 2006-07-21 2006-09-27 Pliva Istrazivanje I Razvoj D Process
EP2069307A4 (en) * 2006-08-04 2010-03-03 Matrix Lab Ltd PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
EP1886998A1 (en) * 2006-08-09 2008-02-13 Esteve Quimica, S.A. Purification process of montelukast and its amine salts
KR20090080038A (ko) * 2006-09-15 2009-07-23 씨아이피엘에이 엘티디. 몬테루카스트의 제조방법 및 그의 중간체
GB0618703D0 (en) * 2006-09-22 2006-11-01 Almac Sciences Ltd Synthesis of leikotriene compounds
US7700776B2 (en) 2006-10-24 2010-04-20 Formosa Laboratories, Inc. Compounds and preparation for montelukast sodium
WO2008058118A2 (en) * 2006-11-06 2008-05-15 Dr. Reddy's Labortories, Ltd. Preparation of montelukast and its salts
WO2008062478A2 (en) * 2006-11-20 2008-05-29 Manne Satyanarayana Reddy Improved process for pure montelukast sodium through pure intermediates as well as novel amine salts
KR100774088B1 (ko) * 2006-12-14 2007-11-06 한미약품 주식회사 몬테루카스트의 제조방법 및 이에 사용되는 중간체
US7271268B1 (en) 2006-12-22 2007-09-18 Formosa Laboratories Inc. Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
US20080188664A1 (en) * 2007-01-15 2008-08-07 Chemagis Ltd. Process for preparing montelukast sodium containing controlled levels of impurities
EP1958936A1 (en) * 2007-02-14 2008-08-20 Inke, S.A. Process for obtaining montelukast
WO2008126075A1 (en) * 2007-04-12 2008-10-23 Chemagis Ltd. Process for preparing montelukast and salts thereof using optically impure 2-(2-(3(s)-(3-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-hydroxypropyl)phenyl-2-propanol
PL205444B1 (pl) * 2007-05-02 2010-04-30 Zak & Lstrok Ady Farmaceutyczn Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego
WO2008135966A1 (en) * 2007-05-02 2008-11-13 Chemagis Ltd. Process for the purification of optically impure 2-(2-(3(s)-(3-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-hydroxy-propyl)phenyl-2-propanol
CZ302518B6 (cs) * 2007-07-09 2011-06-29 Zentiva, A. S. Zpusob izolace a cištení montelukastu
EP2014633A1 (en) 2007-07-13 2009-01-14 Lonza Ag Process for the production of tertiary alcohols
ES2320077B1 (es) 2007-07-31 2010-02-26 Moehs Iberica, S.L. Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo.
WO2009027990A1 (en) * 2007-08-29 2009-03-05 Morepen Laboratories Limited Salts of montelukast and process therefor
KR101072896B1 (ko) 2007-10-09 2011-10-17 한미홀딩스 주식회사 이온성 액체 매개체를 이용한 몬테루카스트산의 제조 방법
US20100305080A1 (en) * 2007-10-25 2010-12-02 O'shea Paul Novel Crystalline Salts of Montelukast
EP2053043A1 (en) 2007-10-26 2009-04-29 Inke, S.A. Crystalline salt of montelukast
DE102007061630B4 (de) 2007-12-20 2013-07-04 Formosa Laboratories, Inc. Neue Verbindungen und Herstellung von Montelukast-Natrium
US20100292251A1 (en) * 2008-01-07 2010-11-18 Torrent Pharmaceuticals Limited Montelukast benzhydryl piperazine salts and process for preparation thereof
CN101817818B (zh) * 2008-03-06 2011-10-26 台耀化学股份有限公司 一种用于制备孟鲁司特钠的化合物
CN101323589B (zh) * 2008-03-06 2010-10-06 台耀化学股份有限公司 化合物及孟鲁司特钠的制备方法
EP2265586A4 (en) * 2008-03-17 2012-10-03 Reddys Lab Ltd Dr PREPARATION OF MONTELUKAST AND ITS SALTS
EP2276739A1 (en) * 2008-04-25 2011-01-26 Synthon B.V. Process for making montelukast intermediates
US9004752B2 (en) * 2008-05-05 2015-04-14 Abbvie, Inc. Method for evaluating the solubility of a crystalline substance in a polymer
ES2605473T3 (es) * 2008-05-26 2017-03-14 Laurus Labs Private Limited Un procedimiento mejorado para la preparación de Montelukast y sus sales
KR101123292B1 (ko) * 2008-09-26 2012-03-19 주식회사 엘지생명과학 몬테루카스트 나트륨염의 제조방법
WO2010064109A2 (en) 2008-12-02 2010-06-10 Mayuka Labs Private Limited An improved process for the preparation of montelukast sodium and its intermediates
WO2010148209A2 (en) * 2009-06-19 2010-12-23 Dr. Reddy's Laboratories Ltd. Preparation of montelukast
WO2011004298A1 (en) 2009-07-09 2011-01-13 Alembic Limited Montelukast hexamethylenediamine salt and its use for the preparation of montelukast sodium
EP2287154A1 (en) 2009-07-14 2011-02-23 KRKA, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast
CN101638381B (zh) 2009-09-02 2012-08-29 鲁南制药集团股份有限公司 孟鲁司特钠中间体的合成方法
WO2011033470A1 (en) 2009-09-16 2011-03-24 Ranbaxy Laboratories Limited Crystalline form of montelukast sodium
EP2486015A1 (en) * 2009-10-09 2012-08-15 DSM IP Assets B.V. Sythesis of optically active intermediate for the preparation of montelukast
US20120259121A1 (en) 2009-12-23 2012-10-11 Pharmathen S.A. Process for the preparation of montelukast and salts thereof
WO2011121091A1 (en) 2010-03-31 2011-10-06 Krka, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
US8471030B2 (en) 2010-12-06 2013-06-25 Orochem Technologies Inc. Purification of montelukast using simulated moving bed
EP2502910A1 (en) 2011-03-15 2012-09-26 Laboratorios Lesvi, S.L. Camphorsulfonic salt of a key Montelukast intermediate
CN102633683B (zh) * 2012-04-06 2014-05-21 盐城市晶华化工有限公司 一种1-羟甲基环丙基乙腈合成方法
EP2850064B1 (en) * 2012-05-18 2018-11-07 Laurus Labs Limited Process for preparation of montelukast sodium
CN103539714A (zh) * 2012-07-16 2014-01-29 上海朴颐化学科技有限公司 1-巯甲基环丙基乙酸及其中间体的制备方法
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
WO2014081616A1 (en) * 2012-11-21 2014-05-30 Merck Sharp & Dohme Corp. Preparation of precursors for leukotriene antagonists
WO2014118796A1 (en) * 2013-01-31 2014-08-07 Melody Healthcare Pvt. Ltd. An in-situ process for the preparation of highly pure montelukast sodium
CN103570618A (zh) * 2013-09-30 2014-02-12 浙江车头制药股份有限公司 一种孟鲁司特钠盐的制备方法
EP3096760A1 (en) 2014-01-22 2016-11-30 Takeda GmbH Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
CN104119270A (zh) * 2014-08-12 2014-10-29 牡丹江恒远药业有限公司 一种孟鲁司特钠的制备方法
CN105085391B (zh) 2015-06-10 2017-08-22 广东默泰同创医药科技有限公司 用作白三烯受体拮抗剂的环丙基不饱和喹啉化合物及应用
CN105541786B (zh) * 2016-01-06 2017-08-08 鲁南贝特制药有限公司 一种孟鲁司特钠侧链中间体及其制备方法
CN109503476A (zh) * 2018-12-26 2019-03-22 哈尔滨珍宝制药有限公司 一种孟鲁司特钠的合成工艺
CN111170939A (zh) * 2019-12-20 2020-05-19 牡丹江恒远药业股份有限公司 一种高纯度孟鲁司特钠及其中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
EP0480717B1 (en) * 1990-10-12 1998-04-15 Merck Frosst Canada Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
EP0480716A1 (en) * 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
US5358946A (en) * 1992-05-29 1994-10-25 The Du Pont Merck Pharmaceutical Company Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
US5270234A (en) * 1992-10-30 1993-12-14 International Business Machines Corporation Deep submicron transistor fabrication method
CA2111372C (en) * 1992-12-22 2007-01-16 Robert N. Young Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists
US5371096A (en) * 1993-08-27 1994-12-06 Ciba-Geigy Corporation (3-pyridyl)tetrafuran-2-yl substituted carboxylic acids

Also Published As

Publication number Publication date
BG100638A (bg) 1997-03-31
CA2179407C (en) 2009-03-17
HRP941022B1 (en) 1999-12-31
ES2122534T3 (es) 1998-12-16
US5614632A (en) 1997-03-25
CN101081834B (zh) 2011-08-24
UA44724C2 (uk) 2002-03-15
TW416948B (en) 2001-01-01
NZ278263A (en) 1998-04-27
ATE169906T1 (de) 1998-09-15
KR100319336B1 (ko) 2002-04-22
CA2179407A1 (en) 1995-07-06
TW448160B (en) 2001-08-01
HRP941022A2 (en) 1997-06-30
PL178671B1 (pl) 2000-05-31
DE69412644T2 (de) 1999-02-11
HU226394B1 (en) 2008-11-28
CY2104B1 (en) 2002-04-05
LV12313B (en) 1999-11-20
DK0737186T3 (da) 1999-02-08
JPH09507235A (ja) 1997-07-22
AU686303B2 (en) 1998-02-05
YU49412B (sh) 2006-01-16
JP3640962B2 (ja) 2005-04-20
HUT76279A (en) 1997-07-28
LV12313A (lv) 1999-07-20
DE69412644D1 (de) 1998-09-24
GEP20012387B (en) 2001-03-25
CZ286079B6 (cs) 2000-01-12
US6320052B1 (en) 2001-11-20
CZ187896A3 (en) 1996-12-11
HK1009269A1 (en) 1999-05-28
WO1995018107A1 (en) 1995-07-06
FI962641A (fi) 1996-06-26
CN1326837C (zh) 2007-07-18
PL315155A1 (en) 1996-10-14
FI962641A0 (fi) 1996-06-26
YU77594A (sh) 1997-09-30
AU1444895A (en) 1995-07-17
CN101081834A (zh) 2007-12-05
EP0737186B1 (en) 1998-08-19
HU9601775D0 (en) 1996-09-30
RU2225398C2 (ru) 2004-03-10
CN1139429A (zh) 1997-01-01
CN1046712C (zh) 1999-11-24
FI113045B (fi) 2004-02-27
RU2140909C1 (ru) 1999-11-10
EP0737186A1 (en) 1996-10-16
CN1219535A (zh) 1999-06-16
BG62850B1 (bg) 2000-09-29
RO119018B1 (ro) 2004-02-27

Similar Documents

Publication Publication Date Title
BR9408452A (pt) Processo para preparação de um composto e composto obtido
BR9302065A (pt) Processo para a preparação de um composto
ES509242A0 (es) "procedimiento para preparar nuevos compuestos de cefem".
EP0916646A3 (en) Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL88303A (en) Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid
PT82381B (pt) Processo aperfeicoado para a preparacao de agentes antibacterianos de acido quinolino-3-carboxilico
PT81476B (pt) Processo para a preparacao de derivados do acido quinolono-carboxilico
ES2005746A6 (es) Un procedimiento para la preparacion de un haluro de piridinio.
PT84092B (pt) Processo aperfeicoado para a preparacao de agentes anti-bacterianos de acido quinolina-3-carboxilicos
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
ES8606283A1 (es) Procedimiento para preparar derivados de acidos quinolon- carboxilicos
AU4682985A (en) 2-(3,5-Dislkyl -4- Hydroxyphenyl) indole derivatives
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
JPS55104295A (en) Pyrimidin-4-yl(thio)phosphoric acid ester, its preparation, and insecticide, miticide, and nematocide containing the compound as effective component
BR9902264A (pt) Composto, e, processo para a fabricação do mesmo
AR240822A2 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo[4,5-g!quinolina y sus sales
NO914192L (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinoner, fremgangsmaate for fremstilling og anvendelse som medikamenter
PT84062B (pt) Processo para a preparacao de fosfonil hidroxiacil prolinas
ES8706115A1 (es) Procedimiento para preparar un derivado de pirrolidina
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
IT1298541B1 (it) Processo per la preparazione di s-alchilcisteine

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal